Reduction of Lipoprotein(a) With Small Interfering RNA: The Results of the Ocean(a)-DOSE Trial
Michelle L. O’Donoghue, et al.
Investigational product. Safety and effectiveness have not been established
View ABSTRACTWelcome to the Amgen Medical Virtual Exhibit
Data Presentations
Risk for Incident Coronary Heart Disease Associated with High Lipoprotein(a) by Levels of Factor VIII and High-Sensitivity C-reactive Protein
Lisandro D. Colantonio, et al.
View ABSTRACTSome abstracts/presentations reflect data, analyses, and/or views of third parties that have not been supported by or adopted by Amgen.